206 related articles for article (PubMed ID: 31537884)
21. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
[TBL] [Abstract][Full Text] [Related]
22. The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro.
Mondal N; Parvin JD
Cancer Biol Ther; 2005 Apr; 4(4):414-8. PubMed ID: 15846087
[TBL] [Abstract][Full Text] [Related]
23. Expression of the p53 family of proteins in central and peripheral human corneal endothelial cells.
Paull AC; Whikehart DR
Mol Vis; 2005 May; 11():328-34. PubMed ID: 15889017
[TBL] [Abstract][Full Text] [Related]
24. Expression of p63 and p73 in ameloblastomas.
Kumamoto H; Ohki K; Ooya K
J Oral Pathol Med; 2005 Apr; 34(4):220-6. PubMed ID: 15752257
[TBL] [Abstract][Full Text] [Related]
25. Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes.
Sasaki Y; Naishiro Y; Oshima Y; Imai K; Nakamura Y; Tokino T
Oncogene; 2005 Jul; 24(32):5131-6. PubMed ID: 15856012
[TBL] [Abstract][Full Text] [Related]
26. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis.
Rocco JW; Leong CO; Kuperwasser N; DeYoung MP; Ellisen LW
Cancer Cell; 2006 Jan; 9(1):45-56. PubMed ID: 16413471
[TBL] [Abstract][Full Text] [Related]
27. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
Muttray AF; Cox RL; Reinisch CL; Baldwin SA
Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
[TBL] [Abstract][Full Text] [Related]
28. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
[TBL] [Abstract][Full Text] [Related]
29. Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants.
Lanza M; Marinari B; Papoutsaki M; Giustizieri ML; D'Alessandra Y; Chimenti S; Guerrini L; Costanzo A
Cell Cycle; 2006 Sep; 5(17):1996-2004. PubMed ID: 16931914
[TBL] [Abstract][Full Text] [Related]
30. p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis.
Díaz R; Peña C; Silva J; Lorenzo Y; García V; García JM; Sánchez A; Espinosa P; Yuste R; Bonilla F; Domínguez G
Int J Cancer; 2008 Sep; 123(5):1060-7. PubMed ID: 18546269
[TBL] [Abstract][Full Text] [Related]
31. Regulating the genome surveillance system: miRNAs and the p53 super family.
Bailey SG; Sanchez-Elsner T; Stephanou A; Cragg MS; Townsend PA
Apoptosis; 2010 May; 15(5):541-52. PubMed ID: 20091234
[TBL] [Abstract][Full Text] [Related]
32. Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer.
Tannapfel A; Schmelzer S; Benicke M; Klimpfinger M; Kohlhaw K; Mössner J; Engeland K; Wittekind C
J Pathol; 2001 Sep; 195(2):163-70. PubMed ID: 11592094
[TBL] [Abstract][Full Text] [Related]
33. P63 in health and cancer.
Gonfloni S; Caputo V; Iannizzotto V
Int J Dev Biol; 2015; 59(1-3):87-93. PubMed ID: 26374530
[TBL] [Abstract][Full Text] [Related]
34. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S
J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic prospects for p73 and p63: rising from the shadow of p53.
Vilgelm A; El-Rifai W; Zaika A
Drug Resist Updat; 2008; 11(4-5):152-63. PubMed ID: 18801697
[TBL] [Abstract][Full Text] [Related]
36. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
[TBL] [Abstract][Full Text] [Related]
37. Questioning the oncogenic role of DeltaNp73alpha in different cell lines expressing p53 or not.
Marrazzo E; Marchini S; Previdi S; Broggini M
Cancer Biol Ther; 2006 Jul; 5(7):794-803. PubMed ID: 16721041
[TBL] [Abstract][Full Text] [Related]
38. p53 family update: p73 and p63 develop their own identities.
Irwin MS; Kaelin WG
Cell Growth Differ; 2001 Jul; 12(7):337-49. PubMed ID: 11457731
[No Abstract] [Full Text] [Related]
39. p63 and p73 transactivate differentiation gene promoters in human keratinocytes.
De Laurenzi V; Rossi A; Terrinoni A; Barcaroli D; Levrero M; Costanzo A; Knight RA; Guerrieri P; Melino G
Biochem Biophys Res Commun; 2000 Jun; 273(1):342-6. PubMed ID: 10873608
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease.
Chen S; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu Y; Furue M
Clin Exp Dermatol; 2008 Aug; 33(5):634-40. PubMed ID: 18627398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]